Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Colistin-induced Nephrotoxicity
NCT05613361Phase 3Unknown
- Sponsor
- October 6 University
- Start
- Jan 2023
- Primary completion
- Apr 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of curcumin in acute kidney injury (AKI), nephropathy, sponsored by October 6 University. Status: unknown.
02
Drugs
curcumin
03
Conditions
acute kidney injury (AKI)nephropathy
Beyond the preview
Go deeper on NCT05613361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05613361.